|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.807
|
|
|
|
naphthalene metabolic process
|
GO:0018931 |
1 |
0.663
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.547
|
|
|
|
vitamin d3 metabolic process
|
GO:0070640 |
3 |
0.546
|
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.529
|
|
|
|
naphthalene containing compound metabolic process
|
GO:0090420 |
1 |
0.501
|
|
|
|
renal tubular secretion
|
GO:0097254 |
2 |
0.500
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.473
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.465
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.437
|
|
|
|
cellular alcohol metabolic process
|
GO:0044107 |
3 |
0.392
|
|
|
|
secondary alcohol metabolic process
|
GO:1902652 |
3 |
0.389
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.377
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.370
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.346
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.343
|
|
|
|
calcitriol biosynthetic process from calciol
|
GO:0036378 |
3 |
0.317
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.280
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.274
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.256
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.251
|
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.250
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.248
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.237
|
|
|
|
drug metabolic process
|
GO:0017144 |
4 |
0.230
|
|
|
|
positive regulation of steroid hormone secretion
|
GO:2000833 |
2 |
0.225
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.220
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.206
|
Mouse |
|
|
cellular alcohol biosynthetic process
|
GO:0044108 |
3 |
0.202
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.181
|
|
|
|
response to stilbenoid
|
GO:0035634 |
22 |
0.178
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.177
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.170
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.169
|
|
|
|
short chain fatty acid catabolic process
|
GO:0019626 |
2 |
0.167
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.164
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.164
|
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.161
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.150
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.148
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.142
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.137
|
|
|
|
tetrapyrrole metabolic process
|
GO:0033013 |
22 |
0.137
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.136
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.135
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.131
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
23 |
0.131
|
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.129
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.128
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.126
|
Mouse |
|
|
fat soluble vitamin metabolic process
|
GO:0006775 |
11 |
0.125
|
|
|
|
response to phenylpropanoid
|
GO:0080184 |
22 |
0.125
|
|
|
|
regulation of blood vessel size
|
GO:0050880 |
56 |
0.124
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.123
|
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.122
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
51 |
0.118
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.116
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.115
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.115
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.114
|
|
|
|
oxidative demethylation
|
GO:0070989 |
1 |
0.113
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.113
|
|
|
|
drug catabolic process
|
GO:0042737 |
2 |
0.112
|
|
|
|
porphyrin containing compound metabolic process
|
GO:0006778 |
22 |
0.111
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.109
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.106
|
|
|
|
vascular process in circulatory system
|
GO:0003018 |
62 |
0.105
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.102
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.101
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.101
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.100
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.100
|
Mouse |
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.096
|
|
|
|
pigment metabolic process
|
GO:0042440 |
32 |
0.096
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.095
|
|
|
|
arachidonic acid metabolic process
|
GO:0019369 |
14 |
0.094
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.092
|
|
|
|
regulation of estrogen secretion
|
GO:2000861 |
1 |
0.092
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.091
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.091
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.090
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.090
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.089
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.087
|
|
|
|
positive regulation of estrogen secretion
|
GO:2000863 |
1 |
0.084
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.084
|
|
|
|
heme metabolic process
|
GO:0042168 |
16 |
0.084
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.081
|
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.080
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.072
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.070
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.069
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.069
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.068
|
|
|
|
linoleic acid metabolic process
|
GO:0043651 |
6 |
0.067
|
|
|
|
endothelial cell differentiation
|
GO:0045446 |
41 |
0.067
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.067
|
|
|
|
regulation of systemic arterial blood pressure
|
GO:0003073 |
61 |
0.066
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.066
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.065
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.064
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.064
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.063
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.062
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.062
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.062
|
|
|
|
unsaturated fatty acid metabolic process
|
GO:0033559 |
31 |
0.061
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.060
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.059
|
Human Mouse |
|
|
endocrine process
|
GO:0050886 |
39 |
0.059
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.059
|
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.058
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.058
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.058
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.058
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.057
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.057
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.056
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.056
|
|
|
|
long chain fatty acid metabolic process
|
GO:0001676 |
26 |
0.056
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.056
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.056
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.055
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.055
|
|
|
|
negative regulation of iron ion transport
|
GO:0034757 |
1 |
0.055
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.055
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.054
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.054
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.054
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.054
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.053
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.053
|
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.053
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.053
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.053
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.053
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.053
|
|
|
|
testosterone biosynthetic process
|
GO:0061370 |
2 |
0.053
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.052
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.052
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.052
|
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.052
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.051
|
|
|
|
polyol metabolic process
|
GO:0019751 |
26 |
0.050
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.050
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.050
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.049
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.049
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.049
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.049
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.049
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.048
|
|
|
|
regulation of blood vessel size by renin angiotensin
|
GO:0002034 |
5 |
0.048
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.048
|
Human |
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.046
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.046
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.045
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.045
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.044
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.044
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.044
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.043
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.043
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.043
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.043
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.043
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.042
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.042
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.042
|
|
|
|
fatty acid derivative metabolic process
|
GO:1901568 |
33 |
0.042
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.041
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.041
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.041
|
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.041
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.040
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.040
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.040
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.040
|
|
|
|
female meiosis chromosome segregation
|
GO:0016321 |
1 |
0.040
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.040
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.039
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.039
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.038
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.038
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.038
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.038
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.037
|
|
|
|
regulation of vitamin d biosynthetic process
|
GO:0060556 |
1 |
0.037
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.037
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.037
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.037
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.037
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.036
|
|
|
|
response to transition metal nanoparticle
|
GO:1990267 |
11 |
0.036
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.036
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.036
|
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.036
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.036
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.036
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.036
|
|
|
|
estrogen secretion
|
GO:0035937 |
1 |
0.035
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.035
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.035
|
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.034
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.034
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.034
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.034
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.033
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.033
|
|
|
|
cellular response to metal ion
|
GO:0071248 |
31 |
0.033
|
|
|
|
icosanoid metabolic process
|
GO:0006690 |
33 |
0.033
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.033
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.033
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.033
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.033
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.032
|
|
|
|
vitamin a metabolic process
|
GO:0006776 |
2 |
0.032
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.032
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.032
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.032
|
|
|
|
positive regulation of lipid transport
|
GO:0032370 |
22 |
0.032
|
|
|
|
dibenzo p dioxin metabolic process
|
GO:0018894 |
1 |
0.031
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.030
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.030
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.030
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.030
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.030
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.030
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.030
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.030
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.030
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.030
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.029
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.029
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.029
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.029
|
|
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.029
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.029
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.029
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.029
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.028
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.028
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.028
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.028
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.028
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.027
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.027
|
|
|
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.027
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.027
|
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.027
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.027
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.027
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.027
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
vitamin biosynthetic process
|
GO:0009110 |
7 |
0.026
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.025
|
|
|
|
positive regulation of blood pressure
|
GO:0045777 |
21 |
0.025
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.025
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.025
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.025
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.025
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.025
|
|
|
|
regulation of endocrine process
|
GO:0044060 |
13 |
0.025
|
|
|
|
branching involved in ureteric bud morphogenesis
|
GO:0001658 |
56 |
0.025
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.024
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.024
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.024
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.024
|
Mouse |
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.024
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.024
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.024
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.024
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.024
|
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.023
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.023
|
Mouse |
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.023
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.023
|
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.023
|
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.023
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.023
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.023
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.023
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.023
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.023
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.023
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.023
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.023
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.023
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.022
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.022
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.022
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.022
|
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.022
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.022
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.022
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.022
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.022
|
|
|
|
response to cadmium ion
|
GO:0046686 |
8 |
0.022
|
|
|
|
insulin processing
|
GO:0030070 |
2 |
0.021
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.021
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.021
|
|
|
|
positive regulation of systemic arterial blood pressure
|
GO:0003084 |
9 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.021
|
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.021
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
|
|
|
foregut regionalization
|
GO:0060423 |
3 |
0.021
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.020
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.020
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.020
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure by renin angiotensin
|
GO:0003081 |
20 |
0.020
|
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.020
|
|
|
|
outer medullary collecting duct development
|
GO:0072060 |
1 |
0.020
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.020
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.020
|
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.020
|
|
|
|
toxin metabolic process
|
GO:0009404 |
5 |
0.019
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.019
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.019
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.019
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.019
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.019
|
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.019
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.019
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
regulation of tyrosine phosphorylation of stat1 protein
|
GO:0042510 |
2 |
0.019
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.019
|
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.019
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.019
|
|
|
|
negative regulation of peptide secretion
|
GO:0002792 |
16 |
0.018
|
|
|
|
response to alkaloid
|
GO:0043279 |
34 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
activation of adenylate cyclase activity
|
GO:0007190 |
4 |
0.018
|
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.018
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.018
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.018
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.018
|
|
|
|
endocrine hormone secretion
|
GO:0060986 |
15 |
0.018
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.018
|
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.018
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.018
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.018
|
|
|
|
photoreceptor cell development
|
GO:0042461 |
40 |
0.018
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.018
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.018
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.018
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.018
|
|
|
|
eye photoreceptor cell differentiation
|
GO:0001754 |
41 |
0.018
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.018
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.018
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
16 |
0.017
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.017
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.017
|
|
|
|
vasoconstriction
|
GO:0042310 |
27 |
0.017
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.017
|
|
|
|
secondary metabolic process
|
GO:0019748 |
18 |
0.017
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.017
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.017
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.017
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.017
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.017
|
|
|
|
adiponectin activated signaling pathway
|
GO:0033211 |
4 |
0.017
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.017
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.016
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.016
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.016
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.016
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.016
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.016
|
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.016
|
Mouse |
|
|
renal system process involved in regulation of systemic arterial blood pressure
|
GO:0003071 |
15 |
0.016
|
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.016
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.016
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.016
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.016
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.016
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.016
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.016
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.016
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.016
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.016
|
|
|
|
acyl coa metabolic process
|
GO:0006637 |
19 |
0.016
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.016
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.016
|
|
|
|
response to iron ion
|
GO:0010039 |
4 |
0.016
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.015
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.015
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.015
|
|
|
|
potassium ion transmembrane transport
|
GO:0071805 |
43 |
0.015
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.015
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.015
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.015
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.015
|
|
|
|
9 cis retinoic acid metabolic process
|
GO:0042905 |
5 |
0.015
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.015
|
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.015
|
|
|
|
positive regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014068 |
20 |
0.015
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.015
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.015
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.015
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.015
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.015
|
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.015
|
|
|
|
positive regulation of cholesterol biosynthetic process
|
GO:0045542 |
3 |
0.015
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.015
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
8 |
0.015
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.015
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.015
|
Mouse |
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.015
|
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.015
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.015
|
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.015
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.015
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.015
|
|
|
|
acetylcholine catabolic process
|
GO:0006581 |
1 |
0.015
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.015
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.014
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.014
|
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.014
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.014
|
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.014
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.014
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.014
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.014
|
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.014
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.014
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.014
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.014
|
|
|
|
regulation of urea metabolic process
|
GO:0034255 |
1 |
0.014
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
61 |
0.014
|
|
|
|
response to bile acid
|
GO:1903412 |
1 |
0.014
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.014
|
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.014
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.014
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.014
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.014
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
57 |
0.014
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.014
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.014
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.014
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.014
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
39 |
0.014
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.013
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.013
|
Mouse |
|
|
cholesterol biosynthetic process
|
GO:0006695 |
15 |
0.013
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.013
|
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.013
|
|
|
|
potassium ion transport
|
GO:0006813 |
52 |
0.013
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.013
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.013
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.013
|
|
|
|
steroid hormone secretion
|
GO:0035929 |
9 |
0.013
|
|
|
|
response to testosterone
|
GO:0033574 |
3 |
0.013
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.013
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.013
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.013
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.013
|
|
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.013
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.013
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.013
|
|
|
|
triglyceride mobilization
|
GO:0006642 |
5 |
0.013
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.013
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.013
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.013
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.013
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.013
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.013
|
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.013
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.013
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.013
|
|
